{"symbol": "INCY", "companyName": "Incyte Corporation", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.incyte.com", "description": "Incyte Corp is a biopharmaceutical company. It discovers, develops and commercializes proprietary therapeutics. Its product JAKAFI, a JAK1 and JAK2 inhibitor is used for treatment of patients with intermediate or high risk myelofibrosis.", "CEO": "Herve Hoppenot", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}